Effect of TAXUS-LiberteTM-SR Stent on the Incidence of Cardiovascular Disease in Patients with Non-selective Coronary Heart Disease
Shen Wenyu
Yang Shouzhong
Li Yudong
Abstract：Objective To evaluate the effect of TAXUS-LiberteTM-SR stent on the incidence of cardiovascular disease in patients with non-selective coronary heart disease (CHD).Methods Three hundreds and twenty-eight patients with CHD after coronary artery interventional treatment and juxtaposition in drug eluting stents in January 2012 to December 2014 were selected.Patients were divided into SES group (n=164) and PES group (n=164) according to the stent implantation.The incidence rate of cardiovascular disease (including target lesion revascularization,target vessel revascularization,stent thrombosis rate,mortality,myocardial infarction incidence rate and recurrence rate) were observed.Results After 1 year of follow-up,the target lesion blood transport reconstruction rate,target blood vessel revascularization rates,stent thrombosis formation rate,myocardial infarction incidence,recurrence rate of angina pectoris was 4.88%,6.10%,1.83%,2.44%,10.37% in SES group and 7.93%,9.15%,2.44%,1.83%,10.98% in the PES group.There was no difference in the incidence of cardiovascular disease between two groups (P>0.05).Conclusion The incidence of CHD is consistent in patients with non-selective CHD by TAXUS-LiberteTM-SR eluting stent and sirolimus eluting stent.
Keywords：non-selective coronary heart diseaseTAXUS-LiberteTM-SR stentcardiovascular diseasestent thrombosissirolimus eluting stent
Publication Date：2017-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：4( 537-540 )